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There is a close association between overuse of antibiotics and
emergence of resistance. Surveys worldwide point to a high
prevalence of inappropriate antibiotic use both in hospital based
or community based studies. Inappropriate use is common in
developed as well as developing countries. Overuse of antibiotics
exerts a selection pressure hence changing a largely susceptible
population of organisms to a largely resistant one. Although
antibiotic resistance has a ﬁtness cost, compensatory mutations
can mitigate this ﬁtness cost.
Stewardship is the careful and responsible management of some-
thing entrusted to one’s care. Antibiotic stewardship is now an
important public health function as antibiotic resistance has
become one of the most important clinical challenges today.
Antibiotic stewardship should be practiced at international, na-
tional and institutional levels. At the international level the
World Health Organisation has played a key role in encouraging
all countries to adopt national strategies to contain antibiotic re-
sistance. A national strategy should be a multi-faceted approach
which includes strengthening antibiotic resistance surveillance,
developing and implementing antibiotic guidelines for practi-
tioners, improving access to and upgrading the quality of mi-
crobiological diagnostic facilities, increasing public awareness of
antibiotic resistance and controlling and regulating the use of
antibiotics for both medicinal and non-medicinal purposes.
In Malaysia the Ministry of Health has established a fairly well de-
ﬁned administrative structure for the purpose of antibiotic stew-
ardship. The National Infection and Antibiotic Control Committee
is chaired by the Director General of Health. A National Antibi-
otic Resistance Surveillance System was established in 1990. The
monitoring of antibiotic utilization is also undertaken and two
National Medicines Use surveys has thus far been completed.
Monitoring of antibiotic utilisation in the Ministry of Health state
hospitals is focused on 4 major groups of compounds namely
cephalosporins, carbapenems, quinolones and glycopeptides.
At the institutional level all government hospitals have antibi-
otic formularies and guidelines. However the effectiveness of
antibiotic stewardship at an institution depends very much on
the presence of “champions”. In the private sector doctors can
use any product so long as it is registered by the Drug Control
Authority and consultants operate as independent contractors in
private hospitals. Professional societies also issue practice guide-
lines from time to time but the effectiveness of these guidelines
is questionable.
Other measures in antibiotic stewardship would be the legislative
control of prescription and sales of antibiotics for medicinal use
as well as non-medicinal use and the regulation of marketing and
promotional activities by pharmaceutical companies.
The emergence of resistance is threatening the usefulness of
antibiotics and there is an urgent need to conserve this precious
resource. Antibiotic stewardship is crucial to contain resistance.
A concerted effort employing a multifaceted strategy is essen-
tial at international, national and institutional levels and all
stakeholders need to work together to meet this challenge.
CS10-04 Problems with Empirical Antibiotics in Febrile
Neutropenia
B.H. Tan*. Department of Internal Medicine, Singapore General
Hospital, Singapore
Over the years, numerous well-conducted randomized controlled
trials have provided much information guiding the empirical
use of antibiotics in febrile antibiotics. Monotherapy with cef-
tazidime, cefepime, imipenem or meropenem is well supported
by the data, and is in common use. At the same time, the more
traditional combination of an anti-pseudomonal beta-lactam
with an aminoglycoside continues to be used.
Problems with these approaches have arisen largely because of
rising antibiotic resistance. Outbreaks of metallo-betalactamase
(MBL)-producing organisms have occured in Haematology-
Oncology units, as have outbreaks of vancomycin-resistant en-
terococci (VRE) and Stenotrophonomas maltophilia. These out-
breaks have been attributed in part to the overuse of antibiotics.
There are also problems associated with individual drugs, such
as the purported increase in mortality associated with cefepime
use, the link between piperacillin-tazobactam and false-positive
galactomannan readings, and the link between ceftazidime and
the extended-spectrum beta-lactamases (ESBLs).
These topics will be reviewed in the talk.
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CS11-01 Molecular Epidemiological Study of HIV-1
CRF01_AE Transmission in Hong Kong
Wing Cheong Yam*. Department of Microbiology, Queen Mary
Hospital, The University of Hong Kong, Hong Kong SAR, China
A total of 465 HIV-1 CRF01_AE pol sequences were collected for
phylogentic study by the Bayesian coalescent method. CRF01_AE
patient population included 363 males (78.1%) and 102 females
(21.9%) while 65% (314/465) were local Chinese. Major trans-
mission routes were heterosexual contact (63%), followed by
intravenous drug use (19%) and men having sex with men (MSM)
(17%). From phylogenetic analysis, local CRF01_AE strains were
from multiple origins with 3 separate transmission clusters iden-
tiﬁed. Cluster 1 consisted mainly of Chinese male intravenous
drug users (IDU) and heterosexual. Cluster 2 and 3 included
mainly local Chinese MSM and non-Chinese Asian IDUs respec-
tively. Chinese reference isolates available from China (Fujian,
Guangxi, or Liaoning) were clonally related to our transmission
clusters, demonstrating the epidemiological linkage of CRF01_AE
infections between Hong Kong and China. The 3 individual lo-
cal transmission clusters were estimated to have initiated since
late-80s and late-90s, causing subsequent epidemics in the early-
2000s. This is the ﬁrst comprehensive molecular epidemiological
study of HIV-1 CRF01_AE in Hong Kong. It revealed MSM contact
is becoming a major route of local CRF01_AE transmission in
Hong Kong. Epidemiological linkage of CRF01_AE between Hong
Kong and China observed in this study indicates the importance
of regular molecular epidemiological surveillance for the HIV-1
epidemic in our region.
CS11-02 Clinical Retrospective Study of Haemophilia A
Patients with AIDS after Long Term HAART
Hongzhou Lu*. Division of Infectious Diseases, Fudan University,
Shanghai, China
Objcetive: To observe and evaluate the impact of long term
highly active antiretroviral therapy (HAART) in Haemophilia A
patients complicated with AIDS (Haemophilia A/AIDS).
Method: 39 Haemophilia A/AIDS patients undergone HAART for
6 years between 1 June 2002 and 31 July 2008 were enrolled.
The data of Haemophilia A/AIDS patients’ consultation times
(times/year), bleeding times (times/year), VIII factor transfusion
times (times/year), amount of VIII factor transfusion (U/year)
and VIII:C level were analyzed to evaluate haemorrhage status;
grade scales were designed to measure the joint function and
physical ability. Then the data of HIV virus load and CD4+ cells
count were also observed to evaluate the effect of HAART on
immune recovery; ﬁnally, the data of complete blood cell count,
hepatic panel, blood lipid assay, renal function, plasma glucose,
uric acid and blood amylase were also observed to evaluate side
effect of long term HAART.
Results: After 6 years of HAART, no obvious change could be seen
in Haemophilia A/AIDS patients’ mean consultation times, mean
bleeding times, mean VIII factor transfusion times and mean
amount of VIII factor transfusion (P>0.05), only one case exhib-
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ited moderate decrease in VIII:C level, one case manifested slight
decline in physical ability, one case manifested slight decline in
joint function. Meanwhile, both the decreasing of HIV RNA load
and the increasing of CD4+ T cell count were notable (P<0.05). It
is showed no statistics change could be seen in complete blood
cell count after 6 years of HAART, however, the mean hemoglobin
level of all 39 patients had decreased slightly blow normal range.
It also showed, serum alanine aminitransperase (ALT) increased
to a level which moderately above normal span but without
statistics signiﬁcance, however, triglyceride and uric acid were
markedly higher compared with the data before HAART (P<0.05);
no statistics difference could be seen in aspartate transaminase
(AST), serum bilirubin (SB), blood amylase, blood urea nitrogen,
blood creatinine and fasting plasma glucose (P>0.05).
Conclusion: Long term HAART is likely to have limited im-
pact on haemorrhage status, joint function and physical ability
in Haemophilia A/AIDS patients; however, HAART therapy is
effective to inhibit HIV replication and promote CD4+ cells prolif-
eration which indicates HAART is positive for immune recovery,
moreover, Long term HAART could induce animia, hepatic dam-
age, hyperlipidemia and hyperuricemia and which may widely
exist.
CS11-03 Promoting HIV Screening and Voluntary
Counselling and Testing as Important Public
Health Interventions
David P. Wilson*. National Centre in HIV Epidemiology and
Clinical Research, University of New South Wales
Aims: Individuals who are diagnosed as HIV-positive tend to
change behavior to reduce transmission to others. The aims of
this work are to estimate the expected epidemiological impacts
of increasing HIV testing rates; to determine what testing levels
are required for serosorting to be an effective risk reduction
strategy for HIV-negative individuals; and to recommend optimal
testing rates for different settings and epidemics.
Methods: Extensive reviews were carried out of the social-
behavioral, biological, clinical, and epidemiological HIV litera-
ture relevant to numerous countries. These diverse data sources
were incorporated into mathematical models that simulated
complex mixing patterns and polymorphous sexual and injecting
behaviors among numerous population subgroups, the transmis-
sion of HIV throughout the population, along with tracking of
the disease progression and clinical outcomes of HIV-infected
individuals. The models were used to simulate the past and cur-
rent trends of HIV epidemics, identify key drivers, and forecast
expected future trends according to current conditions and due
to implementation of targeted intervention strategies focused
on voluntary counseling and testing (VCT) and routine screen-
ing. The models were coupled with uncertainty and sensitivity
analyses.
Results: There is a disproportionate association between undiag-
nosed status and HIV transmission. For example, it is estimated
that in Australia, where testing rates are relatively high, ap-
proximately 30% of new HIV infections are transmitted from the
∼10-15% of HIV infections that are undiagnosed. Similar dispro-
portionate associations exist in other locations. Even modest
increases in HIV testing rates could have substantial epidemi-
ological consequences in all settings, particularly in countries
where rates are currently low.
Surprisingly, it was found that the practice of serosorting to
reduce the risk of HIV acquisition likely increases the risk of HIV
in most settings; testing rates would need to be sufﬁciently high
such that the proportion of infections that are undiagnosed is
less than 20% for serosorting to be effective.
The appropriate goals for testing frequency and coverage rates
vary considerably between locations. However, increases in cov-
erage among the right target groups, if accompanied by even
relatively small behavior change, can be sufﬁcient to lead to sig-
niﬁcant public health control of HIV epidemics. In most settings,
public health goals should be at least regular annual testing of
individuals at relatively high risk and up to 4 times per year
for individuals at very high risk of HIV infection. Testing-based
interventions can be expected to have a noticeable impact within
a few years and the beneﬁts will also increase over time.
Conclusions: Promoting increases in the coverage and frequency
of HIV testing, particularly among people at high risk, could
be a highly-effective public health intervention. It is important
to provide easy access to VCT sites and make HIV screening a
more regular and routine component of clinical consultations.
This must be coupled with educational messages that encour-
age testing and make it more acceptable within given cultural
environments.
CS11-04 Sustaining First-line Antiretroviral Regimens:
The Third World Experience
Christopher K.C. Lee*. Infectious Diseases Unit, Sungai Buloh
Hospital, Malaysia
Long-term success with Highly Active Antiretroviral therapy
(HAART) is a realistic and achievable goal for people living with
HIV-1 infection even in resource limited settings. There is now
ever growing evidence of continuing improvements in the clinical
management and treatment outcomes of people living with HIV-1
infection. This has facilitated our understanding of the contribut-
ing factors that determine durable success. The epidemiologic
evidence of success with HAART in suppressing HIV-1 replication
and preventing AIDS progression and death is now overwhelming.
Walensky et al estimated that 2.3 million life-years were saved
by antiretroviral therapy in the United States from 1996-2004.
A key determinant in ensuring long-term success is the selec-
tion of the initial antiretroviral regimen. The “ideal” regimen
should have high potency, convenient dosing, and minimal short
as well as long-term adverse effects. Of equal importance is the
timeliness of treatment initiation which has been recommended
to commence before the development of AIDS deﬁning events.
Various strategies to ensure optimal medication adherence and
patient participation has been utilized to maximize good clinical
outcome. These adherence programs must be consistent and
acceptable to local culture and practice. Often family and com-
munity support has been used as tools to achieve good medical
adherence. This is of particular importance in countries with
limited second-line antiretroviral options; where most patients
realistically have but one therapeutic chance to achieve good and
sustained viral suppression. Speciﬁc attention to comorbidities
including drug use, that may affect treatment outcomes must
also be considered and addressed. The HAART experience from
countries with limited resources will be discussed to illustrate
the above key information.
Concurrent Session 12 – Management of Hepatitis B
Patients
CS12-01 Diagnosis and Monitoring of Hepatitis B Patients
Qing Xie*. Department of Infectious Disease, Ruijin Hospital,
Shanghai Jiaotong University, School of Medicine, Shanghai,
China
CS12-02 Hepatitis B Vaccination in Children
Yen-Hsuan Ni *. Department of Pediatrics, College of Medicine
and Children’s Hospital, National Taiwan University, Taipei,
Taiwan
The world’s ﬁrst nationwide hepatitis B virus (HBV) universal vac-
